These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Adeno-Associated Virus Vector Design-Moving the Adeno-Associated Virus to a Bioengineered Therapeutic Nanoparticle. Jäschke N; Büning H Hematol Oncol Clin North Am; 2022 Aug; 36(4):667-685. PubMed ID: 35778330 [TBL] [Abstract][Full Text] [Related]
4. Chemical Modifications of the Capsid for Redirecting and Improving the Efficacy of Adeno-Associated Virus Vectors. Lam AK; Frabutt D; Li L; Xiao W Hum Gene Ther; 2021 Dec; 32(23-24):1433-1438. PubMed ID: 34254844 [TBL] [Abstract][Full Text] [Related]
7. AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges. Kang L; Jin S; Wang J; Lv Z; Xin C; Tan C; Zhao M; Wang L; Liu J J Control Release; 2023 Mar; 355():458-473. PubMed ID: 36736907 [TBL] [Abstract][Full Text] [Related]
8. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Shi W; Arnold GS; Bartlett JS Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765 [TBL] [Abstract][Full Text] [Related]